INVO Bioscience, Inc. (IVOB.OB) Expands Market for Infertility Treatment
Today, medical device company INVO Bioscience, Inc. announced the signing of three distribution contracts in South and Latin America. The company, focused on treatment options for patients diagnosed with infertility, is looking to the Daxley Group to distribute INVO Bioscience in Columbia, Venezuela, Ecuador, Panama, Mexico, Brazil, Chili, Argentina and Uruguay. Daxley also distributes for Medicult, Conception Technologies, Biogenics and Rocket Medical, all who offer infertility treatment products in said countries. INVO Bioscience’s patented product, the INVOcell, allows for vaginal incubation of eggs, sperm and early embryo development during the infertility treatment process. Dr. Claude Ranoux has been invited to…